BackgroundCheck.run
Search For

Tarun R Patel, 45Carrollton, GA

Known as:
Tarun I Patel Vaishali H Patel Tarun Patel Vaishaliben Vaishaliben T Patel Taru N Patel Tarun R Krishnaben Tapon Patel Turun Patel
Related to:
Rameshbhal A Patel 82

Tarun Patel Phones & Addresses

Carrollton, GA   

Wedowee, AL   

Secaucus, NJ   

Bowdon, GA   

Highland Park, NJ   

Villa Rica, GA   

Piscataway, NJ   

North Bergen, NJ   

Carlton, GA   

207 Summer Chase, Carrollton, GA 30116    770-8321027   

Work

Company: Pricewaterhousecoopers LLP Address: 300 Madison Ave, New York, NY 10017

Education

School / High School: Hofstra University School of Law

Ranks

Licence: New York - Currently registered Date: 2004
Get Report
Control this profile

Mentions for Tarun R Patel

Career records & work history

Lawyers & Attorneys

Tarun Patel Photo 1

Tarun R. Patel, New York NY - Lawyer

Address:
Pricewaterhousecoopers LLP
300 Madison Ave, New York, NY 10017
646-4715573 (Office)
Licenses:
New York - Currently registered 2004
Education:
Hofstra University School of Law
Tarun Patel Photo 2

Tarun Patel - Lawyer

ISLN:
922895876
Admitted:
2004
University:
Hofstra University

Medicine Doctors

Tarun Patel Photo 3

Tarun A Patel

Tarun Patel resumes & CV records

Resumes

Tarun Patel Photo 53

Tarun Patel

Location:
United States
Tarun Patel Photo 54

Tarun Patel

Location:
United States
Tarun Patel Photo 55

Business Operations At Ibm Corp

Position:
Business Operations at IBM Corp
Location:
United States
Industry:
Computer & Network Security
Work:
IBM Corp
Business Operations
Education:
Georgia Institute of Technology
Tarun Patel Photo 56

Tarun Patel - NJ

Work:
Family Grocery Dec 2012 to Aug 2013
Assistant Manager and Data Entry Zealmedia Pc Solution Feb 2008 to Nov 2012
help desktop support/system analyst Chitra Technology pvt.ltd - Ahmedabad, Gujarat 2007 to 2008
Intern Online College Information System 2005 to 2006
Academic Project
Education:
S.P COLLAGE OF ENGINEERING,INDIA 2003 to 2007
Bachelor of Engineering in INFORMATION TECHNOLOGY S.V..P.POLYTECHNIC,INDIA 1999 to 2003
DIPLOMA OF ENGINEERING in COMPUTER ENGINEERING
Skills:
Microsoft office, Microsoft Visio, Microsoft project, Uml tool, Photoshop, Flash,Asp.net, Vb.net, c,MS SQL, MS access,Knowledge of Domain and Webhosting with accurate web maintenance
Tarun Patel Photo 57

Tarun Patel - Clifton, NJ

Work:
Konica Minolta Medical Imaging USA, Inc. Jan 2007 to 2000
Senior Applications Systems Analyst V Evident Software - Bloomfield, NJ Jul 2006 to Dec 2007
Managed Services Technical Consultant Epicor Software Corporation - Irvine, CA Sep 2005 to Jul 2006
Implementation Consultant Towers Perrin LLP - Voorhees, NJ Apr 2003 to Sep 2005
Senior Technical Analyst, Implementation Conversion/New Build Team Ernst & Young LLP - Lyndhurst, NJ Jun 2001 to Feb 2002
EYQ Quality Assurance Analyst, Technical Support Service Department Price Waterhouse Coopers LLP - New York, NY Feb 2000 to May 2001
IT Management Consultant, Management Consulting Group Price Waterhouse Coopers LLP - Fort Lee, NJ Feb 2000 to May 2001
Health and Welfare Administration Analyst, Unifi Network Group Merck-Medco Managed Care, LLC - Franklin Lakes, NJ May 1999 to Feb 2000
Junior Database Analyst
Education:
Rutgers College - New Brunswick, NJ 1994 to 1999
Bachelor of Science in Major: Computer Science/Minor: Economics
Tarun Patel Photo 58

Tarun Patel

Location:
United States

Publications & IP owners

Us Patents

Pharmaceutical Composition Comprising 5-Methyl-2 (2'-Chloro-6'-Fluoroanillino) Phen Ylacetic Acid

US Patent:
2008028, Nov 20, 2008
Filed:
Jul 21, 2008
Appl. No.:
12/220060
Inventors:
Rose-Marie Dannenfelser - Bloomfield NJ, US
Vivia Christine Georgousis - West caldwell NJ, US
Maha Y. Khaled - Livingston NJ, US
Tarun S. Patel - Parsippany NJ, US
Joseph Sikora - Saccasunna NJ, US
Barbara Wang - Berkeley Heights NJ, US
International Classification:
A61K 31/195
A61P 29/00
US Classification:
514567
Abstract:
The invention relates to a composition for the treatment of a cyclooxygenase-2-mediated disorder or condition comprising 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof suitable for parenteral administration, and to a method for the treatment of a cyclooxygenase-2-mediated disorder or condition in a human or animal in need of such treatment by parenteral administration of 5-methyl-2-(2′-chloro-6′-fluroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof.

Pharmaceutical Composition Comprising 5-Methyl-2(2'-Chloro-6'-Fluoroanilino)Phenylacetic Acid

US Patent:
2007012, May 31, 2007
Filed:
Oct 7, 2004
Appl. No.:
10/574537
Inventors:
Rose-Marie Dannenfelser - Bloomfield NJ, US
Vivian Georgousis - West Caldwell NJ, US
Maha Khaled - Livington NJ, US
Tarun Patel - Parsippany NJ, US
Joseph Sikora - Succasunna NJ, US
Barbara Wang - Berkeley Heights NJ, US
International Classification:
A61K 31/135
US Classification:
514650000
Abstract:
The invention relates to a composition for the treatment of a cyclooxygenase-2-mediated disorder or condition comprising 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof suitable for parenteral administration, and to a method for the treatment of a cyclooxygenase-2-mediated disorder or condition in a human or animal in need of such treatment by parenteral administration of 5-methyl-2-(2′-chloro-6′-fluroanilino)phenylacetic acid or a pharmaceutically acceptable salt, preferably the potassium salt, thereof.

Possible Relatives

David Patel  Dawood M Patel  Daxa R Patel  Daxaben C Patel  Daxesh T Patel  Daxeshkumar B Patel  Dayalji D Patel  Tarun D Singh  Tarun K Arora  Tarun Bhardwaj 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.